UnknownPhase 2

Efficacy and Safety of Levamisole Combined With Standard Prednisolone in Warm Antibody Autoimmune Hemolytic Anemia.

China100 participantsStarted 2012-04

Plain-language summary

The purpose of this study is to determine whether Levamisole plus prednisone can further improve the efficacy，extend the remission duration and reduce the dosage of prednisone for newly diagnosed warm antibody autoimmune hemolytic anemia.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Clinical and biochemical signs of hemolytic anaemia * Positive Coombs test with anti-IgG or and with anti-CD3d * Newly diagnosed Warm Autoimmune Hemolytic Anemia * Adequate contraceptive measures for women of childbearing potential * informed consent signed Exclusion Criteria: * Active infection which requires antibiotic treatment * Pregnant or lactating women * Epilepsy and mental illness * Kidney and liver function abnormal

What they're measuring

Number of patients in each group in complete or partial remission

Timeframe: one year

Trial details

NCT IDNCT01579110

SponsorInstitute of Hematology & Blood Diseases Hospital, China

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2015-04

View on ClinicalTrials.gov More Anemia trials